A new reverse genetics system for norovirus could aid in the development of novel antiviral therapies and vaccines.
Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...
Researchers hail new trial as ‘important step forward’ in protecting vulnerable populations against fatal virus ...
Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has completed the transfer of the ...
We applaud Gov. Kathy Hochul’s initiatives to protect New Yorkers who can no longer rely on federal health recommendations for vaccines under Health and Human Services Secretary Robert F. Kennedy Jr.
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback